BIOLASE (BIOL) Institutional Ownership $0.08 +0.01 (+14.71%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BIOLASE (NASDAQ:BIOL)CurrentInstitutional OwnershipPercentage8.79%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$6.82MNumber ofInstitutional Sellers(last 12 months)0 Get BIOL Insider Trade Alerts Want to know when executives and insiders are buying or selling BIOLASE stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIOL Institutional Buying and Selling by Quarter Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! BIOLASE Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC143,537$27K0.0%+1,068.0%0.430% 8/7/2023Acadian Asset Management LLC961,739$67K0.0%N/A92.475% 7/18/2023Avantax Planning Partners Inc.544,053$38K0.0%N/A1.738% 5/9/2023Perkins Capital Management Inc.2,723,481$766K0.7%+5,795.5%10.344% 1/26/2023Perkins Capital Management Inc.46,196$30K0.0%-65.0%0.598% 11/15/2022Essex Investment Management Co. LLC105,318$256K0.0%+62.3%1.473% Get the Latest News and Ratings for BIOL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Armistice Capital LLC699,000$1.70M0.0%+8.2%10.197% 10/24/2022Perkins Capital Management Inc.132,070$321K0.4%+11.6%1.927% 9/23/2022 Capital Wealth Alliance LLC68,000$51K0.0%N/A0.993% 8/12/2022Essex Investment Management Co. LLC64,878$297K0.0%-96.0%0.947% 8/2/2022 Capital Wealth Alliance LLC68,000$51K0.0%N/A1.100% 7/29/2022Perkins Capital Management Inc.118,300$542K0.6%-96.1%1.915% 5/9/2022Essex Investment Management Co. LLC1,621,992$573K0.1%+2.5%26.271% 5/4/2022Commonwealth Equity Services LLC101,046$35K0.0%+117.8%0.065% 2/10/2022Essex Investment Management Co. LLC1,582,711$617K0.1%+98.0%1.033% 2/10/2022Acadian Asset Management LLC80,790$31K0.0%N/A0.053% 2/10/2022Perkins Capital Management Inc.3,047,030$1.19M0.8%-2.8%1.988% 11/15/2021Marshall Wace LLP752,003$481K0.0%N/A0.497% 11/15/2021Atom Investors LP47,168$30K0.0%N/A0.031% 11/15/2021GSA Capital Partners LLP1,254,547$802K0.1%N/A0.830% 11/12/2021Credit Suisse AG46,016$29K0.0%N/A0.030% 11/9/2021Essex Investment Management Co. LLC799,189$511K0.1%N/A0.529% 10/29/2021Commonwealth Equity Services LLC49,396$31K0.0%N/A0.033% 9/17/2021Virtu Financial LLC220,473$154K0.0%N/A0.146% 8/16/2021State Street Corp541,194$378K0.0%+4,346.6%0.360% 8/16/2021Goldman Sachs Group Inc.172,521$120K0.0%+67.8%0.115% 8/13/2021Renaissance Technologies LLC1,481,536$1.03M0.0%-33.4%0.985% 8/13/2021Geode Capital Management LLC1,209,039$844K0.0%+1.5%0.804% 8/13/2021Vanguard Group Inc.6,971,925$4.87M0.0%-5.0%4.636% 8/11/2021BlackRock Inc.3,010,754$2.10M0.0%-16.0%2.002% 8/10/2021DCM Advisors LLC97,000$68K0.0%-19.2%0.064% 5/19/2021 MONECO Advisors LLC35,000$30K0.0%N/A0.023% 5/18/2021Millennium Management LLC205,964$174K0.0%N/A0.137% 5/18/2021Citadel Advisors LLC387,784$327K0.0%N/A0.258% 5/17/2021Goldman Sachs Group Inc.102,817$87K0.0%N/A0.068% 5/13/2021Renaissance Technologies LLC2,223,284$1.87M0.0%+1,140.0%1.477% 5/12/2021Northern Trust Corp276,060$233K0.0%+184.0%0.183% 5/12/2021Geode Capital Management LLC1,191,258$1.00M0.0%+137.0%0.791% 5/7/2021BlackRock Inc.3,583,531$3.02M0.0%+1,225.7%2.380% 4/28/2021Perkins Capital Management Inc.1,655,500$1.40M0.8%+36.1%1.100% Nvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately.4/20/2021CFO4Life Group LLC33,200$28K0.0%N/A0.022% 2/24/2021Virtu Financial LLC143,370$60K0.0%-46.7%0.098% 2/23/2021Orion Capital Management LLC70,000$29K0.0%N/A0.075% 2/17/2021Invenomic Capital Management LP607,420$253K0.1%+1,103.5%0.650% 2/16/2021Squarepoint Ops LLC515,900$215K0.0%N/A0.552% 2/10/2021Renaissance Technologies LLC179,300$75K0.0%N/A0.192% 2/9/2021Perkins Capital Management Inc.1,216,250$507K0.3%+9.5%1.301% 2/4/2021GSA Capital Partners LLP195,805$82K0.0%N/A0.209% 12/11/2020Virtu Financial LLC269,185$74K0.0%+1,908.5%0.288% 10/28/2020Perkins Capital Management Inc.1,111,000$306K0.3%N/A1.205% 8/17/2020Jane Street Group LLC107,216$50K0.0%N/A0.213% 8/14/2020Oracle Investment Management Inc.1,739,100$1M0.1%-66.4%3.455% (Data available from 1/1/2016 forward) BIOL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIOL shares? During the previous two years, the following institutional investors and hedge funds held shares of BIOLASE shares: Armistice Capital LLC ($1.70M), Perkins Capital Management Inc. ($766K), Essex Investment Management Co. LLC ($256K), Acadian Asset Management LLC ($67K), Capital Wealth Alliance LLC ($51K), and Avantax Planning Partners Inc. ($38K), and Virtu Financial LLC ($27K).Learn more on BIOL's institutional investors. What percentage of BIOLASE stock is owned by institutional investors? 8.79% of BIOLASE stock is owned by institutional investors. Learn more on BIOL's institutional investor holdings. Which institutional investors have been buying BIOLASE stock? The following institutional investors have purchased BIOLASE stock in the last 24 months: Perkins Capital Management Inc. ($2.69M), Acadian Asset Management LLC ($961.74K), Avantax Planning Partners Inc. ($544.05K), Capital Wealth Alliance LLC ($136K), Virtu Financial LLC ($131.25K), Armistice Capital LLC ($52.89K), and Essex Investment Management Co. LLC ($40.44K). How much institutional buying is happening at BIOLASE? Institutional investors have bought a total of 4,557,422 shares in the last 24 months. This purchase volume represents approximately $174.27M in transactions. Which BIOLASE major shareholders have been selling company stock? The following institutional investors have sold BIOLASE stock in the last 24 months: Perkins Capital Management Inc. ($3.03M), and Essex Investment Management Co. LLC ($1.56M). How much institutional selling is happening at BIOLASE? Institutional investors have sold a total of 4,590,718 shares in the last 24 months. This volume of shares sold represents approximately $2.07B in transactions. Related Companies: Biomerica Major Shareholders PAVmed Major Shareholders Sonendo Major Shareholders Intelligent Bio Solutions Major Shareholders Sharps Technology Major Shareholders Sintx Technologies Major Shareholders Avinger Major Shareholders Tenon Medical Major Shareholders Acutus Medical Major Shareholders Bluejay Diagnostics Major Shareholders This page (NASDAQ:BIOL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.